Variation in the peroxisome proliferator-activated receptor δ gene in relation to common metabolic traits in 7,495 middle-aged white people

Diabetologia

Volumn 50, Issue 6, 2007, Pages 1201-1208

  Grarup, N ^a,b   Albrechtsen, A ^a,c   Ek, J ^a,d   Borch Johnsen, K ^a,b,e   Jorgensen T ^e   Schmitz, O ^f,g   Hansen, T ^a   Pedersen, O ^a,b  

^a STENO DIABETES CENTER   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d JOHN F KENNEDY INSTITUTE   (Denmark)

^e GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY   (Denmark)

Author keywords

Genetic epidemiology; Glucose; Insulin resistance; Metabolic syndrome; PPAR delta; PPARD; Type 2 diabetes

Indexed keywords

ADULT; AEROBIC METABOLISM; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; EXON; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GENOTYPE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; DIABETES MELLITUS, TYPE 2; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOME; GLUCOSE; HUMANS; LIPIDS; LIVER; MALE; MIDDLE AGED; MUSCLE, SKELETAL; POLYMORPHISM, GENETIC; PPAR DELTA; VARIATION (GENETICS);

EID: 34247844401     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0668-2     Document Type: Article

References (39)

1. Andersen G, Hansen T, Pedersen O (2005) Genetics of common forms of glycaemia with pathological impact on vascular biology: are we on the right track? Curr Mol Med 5:261-274
2. Lefebvre P, Chinetti G, Fruchart JC, Staels B (2006) Sorting out the roles of PPARα in energy metabolism and vascular homeostasis. J Clin Invest 116:571-580
3. Semple RK, Chatterjee VK, O'Rahilly S (2006) PPARγ and human metabolic disease. J Clin Invest 116:581-589
4. Chawla A, Lee CH, Barak Y et al (2003) PPARα is a very low-density lipoprotein sensor in macrophages. Proc Natl Acad Sci USA 100:1268-1273
5. Lee CH, Kang K, Mehl IR et al (2006) Peroxisome proliferator-activated receptor δ promotes very low-density lipoprotein-derived fatty acid catabolism in the macrophage. Proc Natl Acad Sci USA 103:2434-2439
6. Wang YX, Zhang CL, Yu RT et al (2004) Regulation of muscle fiber type and running endurance by PPARδ. PLoS Biol 2:e294
7. Luquet S, Lopez-Soriano J, Holst D et al (2003) Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J 17:2299-2301
8. Lee CH, Olson P, Hevener A et al (2006) PPARδ regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci USA 103:3444-3449
9. Wang YX, Lee CH, Tiep S et al (2003) Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113:159-170
10. Tanaka T, Yamamoto J, Iwasaki S et al (2003) Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA 100:15924-15929
11. Oliver WR, Shenk JL, Snaith MR et al (2001) Aselective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 98:5306-5311
12. Leibowitz MD, Fiévet C, Hennuyer N et al (2000) Activation of PPAR?̈ alters lipid metabolism in db/db mice. FEBS Lett 473:333-336
13. Watt MJ, Southgate RJ, Holmes AG, Febbraio MA (2004) Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) ?́ and ?̈ and PPAR coactivator 1α in human skeletal muscle, but not lipid regulatory genes. J Mol Endocrinol 33:533-544
14. Mahoney DJ, Parise G, Melov S, Safdar A, Tarnopolsky MA (2005) Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J 19:1498-1500
15. Skogsberg J, McMahon AD, Karpe F, Hamsten A, Packard CJ, Ehrenborg E (2003) Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men. J Intern Med 254:597-604
16. Skogsberg J, Kannisto K, Cassel TN, Hamsten A, Eriksson P, Ehrenborg E (2003) Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men. Arterioscler Thromb Vasc Biol 23:637-643
17. Aberle J, Hopfer I, Beil FU, Seedorf U (2006) Association of the T+294C polymorphism in PPARδ with low HDL cholesterol and coronary heart disease risk in women. Int J Med Sci 3:108-111
18. Chen S, Tsybouleva N, Ballantyne CM, Gotto AM, Marian AJ (2004) Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study. Pharmacogenetics 14:61-71
19. Gouni-Berthold I, Giannakidou E, Faust M, Berthold HK, Krone W (2005) The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls. Atherosclerosis 183:336-341
20. Aberle J, Hopfer I, Beil FU, Seedorf U (2006) Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V. Int J Obes (Lond) 30:1709-1713
21. Robitaille J, Gaudet D, Perusse L, Vohl MC (2007) Features of the metabolic syndrome are modulated by an interaction between the peroxisome proliferator-activated receptor-delta?-87T>C polymorphism and dietary fat in French-Canadians. Int J Obes (Lond) 31:411-417
22. Vänttinen M, Nuutila P, Kuulasmaa T et al (2005) Single nucleotide polymorphisms in the peroxisome proliferator-activated receptorδ gene are associated with skeletal muscle glucose uptake. Diabetes 54:3587-3591
23. Andrulionyte L, Peltola P, Chiasson JL, Laakso M (2006) Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 55:2148-2152
24. Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). Eur J Cardiovasc Prev Rehab 10:377-386
25. World Health Organization Study Group (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Tech Rep Ser WHO/NCD/NCS/99, 2nd edn.World Health Organization, Geneva
26. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
28. Xiao W, Oefner PJ (2001) Denaturing high-performance liquid chromatography: a review. Hum Mutat 17:439-474
29. The International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299-1320
30. Carlson CS, Eberle MA, RiederMJ, Yi Q, Kruglyak L, Nickerson DA (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74:106-120
31. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434
32. Lake SL, Lyon H, Tantisira K et al (2003) Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 55:56-65
33. Doerge RW, Churchill GA (1996) Permutation tests for multiple loci affecting a quantitative character. Genetics 142:285-294
34. Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765-769
35. Gabriel SB, Schaffner SF, Nguyen H et al (2002) The structure of haplotype blocks in the human genome. Science 296:2225-2229
36. Barish GD, Narkar VA, Evans RM (2006) PPARδ a dagger in the heart of the metabolic syndrome. J Clin Invest 116:590-597
37. Shin HD, Park BL, Kim LH et al (2004) Genetic polymorphisms in peroxisome proliferator-activated receptor delta associated with obesity. Diabetes 53:847-851
38. de Bakker PIW, Burtt NP, Graham RR et al (2006) Transferability of tag SNPs in genetic association studies in multiple populations. Nat Genet 38:1298-1303
39. Montpetit A, Nelis M, Laflamme P et al (2006) An evaluation of the performance of tag SNPs derived from HapMap in a Caucasian population. PLoS Genet 2:e27